Texas Court Rejects Halt to Kenvue Dividend Amid Tylenol Lawsuit

Texas court rejects AG Paxton's demand to halt Kenvue's dividend payment amid Tylenol safety lawsuits. The court cited lack of jurisdiction over the matter, allowing Kenvue to proceed with the payment. Kenvue Tylenol pregnant women

Court LeAnn Rafferty of Panola Area District Court declined to approve the demand, Reuters reported. In a quick, one-page order provided Friday, Rafferty wrapped up that she lacked jurisdiction over the dividend matter. The decision efficiently removed the method for Kenvue to distribute the repayment.

Jurisdiction Over Dividend Lacking

In October, Paxton filed a legal action against Johnson & Johnson( NYSE: JNJ) and Kenvue, charging the business of misleading pregnant females concerning the safety of Tylenol regardless of evidence suggesting its active component, acetaminophen, may enhance the danger of autism and interest disorders in youngsters.

Complying with the hearing, Kenvue attorney Kim Bueno told Reuters that territory was a decisive element, given that the business is headquartered in New Jersey and integrated in Delaware. “There was no jurisdiction to test that,” she said, highlighting that Texas did not have authority over the dividend choice.

Kenvue to Proceed with Payment

When asked whether Kenvue would move on with the payment, Bueno validated that the company planned to continue. “Yes, absolutely, as they should,” she said. “That is a circulation that’s being made as part of the normal training course of business.”

On Friday, a Texas court decreased to halt an upcoming investor payment by Texas Attorney general of the United States Ken Paxton to restrict Kenvue Inc.’s( NYSE: KVUE) handling and marketing of Tylenol in the middle of continuous lawsuits over the product’s safety for pregnant women.

State attorneys had actually also argued that Kenvue must be disallowed from advertising Tylenol as safe for expecting women while the case proceeds. The court, nonetheless, decreased to enforce such constraints at this stage, leaving the company’s present advertising techniques intact.